Clinical Trials Directory

Trials / Completed

CompletedNCT02077322

Rates of Middle Meatal Synechia Formation Following Functional Endoscopic Sinus Surgery

Rates of Middle Meatal Synechia Formation Following Functional Endoscopic Sinus Surgery: A Double-Blind Randomized Controlled Trial Comparing Gloved Merocel and Silastic Middle Meatal Spacers.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
St. Paul's Hospital, Canada · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Functional endoscopic sinus surgery (FESS) is the best method of surgically treating patients who suffer from sinus disease. Synechiae formation in the nose is the most common complication after sinus surgery. Synechiae describes the adhesion of two opposing mucosal surfaces in the nasal cavity that can cause scarring and obstruction of the nasal passage. Spacers are often inserted during surgery between nasal mucosal surfaces to prevent synechiae. The aim of this study is to see if a silastic spacer is more effective at reducing the formation of synechiae after sinus surgery than a merocel spacer.

Conditions

Interventions

TypeNameDescription
DEVICESilastic SpacerThe Silastic spacer will be inserted into the middle meatal space after surgery. The spacer will be left in the middle meatus for a period of 6 to 14 days following surgery.
DEVICEMerocel SpacerThe Merocel spacer will be inserted into the middle meatal space after surgery. The spacer will be left in the middle meatus for a period of 6 to 14 days following surgery.

Timeline

Start date
2014-03-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2014-03-04
Last updated
2018-04-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02077322. Inclusion in this directory is not an endorsement.